Zolmitriptan Spray
Product Images NDC 72162-1425

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 72162-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing the estimated probability of response (%) over hours from initial dose for zolmitriptan nasal spray at 2.5 mg and 5.0 mg doses compared to placebo. The 5.0 mg dose shows the highest response, followed by 2.5 mg, with placebo having the lowest response over a 4-hour period.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing the estimated probability of taking an escape medication over 24 hours from initial dose for zolmitriptan nasal sprays at 2.5 mg and 5.0 mg doses versus placebo. The x-axis represents hours from initial dose, and the y-axis shows the estimated probability percentage. The 5.0 mg dose shows the highest probability, followed by placebo, then the 2.5 mg dose.*

FDA Label Image

Figure 3 (Image 03)

A line graph comparing the estimated probability of rescue medication use over time post dose (in hours) between Zolmitriptan 5 mg and placebo groups. The Y-axis shows probability percentages from 0% to 100%, and the X-axis shows time up to 24 hours. The Zolmitriptan group (N=231) is represented by squares, and the placebo group (N=253) by circles, illustrating differences in rescue medication use over time.*

FDA Label Image

Figure-a (Image 04)

An instructional illustration showing hands opening a zolmitriptan nasal spray dose pouch by peeling back the foil. The diagram is labeled Figure A and demonstrates the first step in preparing the zolmitriptan 5 mg/1 spray for nasal administration.*

FDA Label Image

Figure B (Image 05)

Illustration showing a person using their finger to gently block one nostril while preparing to use a nasal spray, indicating the proper technique for nasal administration.*

FDA Label Image

Figure-c (Image 06)

An instructional illustration showing a hand holding a zolmitriptan nasal spray device. The diagram labels the nozzle and plunger parts of the spray mechanism, demonstrating proper handling of the nasal spray product.*

FDA Label Image

Figure D (Image 07)

An instructional line drawing showing a person inserting a nasal spray device into one nostril with the opposite hand pointing upward on the nose. The figure is labeled "Figure D" and illustrates the use of a nasal spray product, likely the zolmitriptan nasal spray.*

FDA Label Image

Chemical-structure (Image 10)

Chemical structure of zolmitriptan, a human prescription drug active ingredient depicted in the image with its molecular framework including indole and oxazolidinone rings.*

FDA Label Image

Label (Lbl721621425)

Label for zolmitriptan nasal spray, USP, 5 mg strength. The label indicates a package containing 6 single-use spray devices. It lists Bryant Ranch Prepack as the relabeler and Padagis as the manufacturer. The label includes storage warnings, dosing reference QR code, and barcodes, with the NDC number 72162-1425-2 visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.